Relafen 750, a advanced preparation of naproxen, represents the intriguing case from our biochemical pharmacy view. The mode of action, essentially involving blocking of cyclooxygenase enzymes and COX-1 and COX-2 – contributes to significant lowering in prostaglandin production. From our biochemical context, it drug's effectiveness is directly as